Our purpose was to evaluate whether the altered conformational state of p53, observed in AD cells, was dependent on an impaired HIPK2 function and, by the use of two cellular models of AD, to define whether a deregulation of HIPK2 is involved in AD pathogenesis. This evidence concerns the gene TP53 and Alzheimer disease.